4-155711252-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001130682.3(GUCY1A1):c.1086+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000345 in 1,450,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001130682.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Moyamoya disease with early-onset achalasiaInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001130682.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GUCY1A1 | NM_001130682.3 | MANE Select | c.1086+1G>T | splice_donor intron | N/A | NP_001124154.1 | |||
| GUCY1A1 | NM_000856.6 | c.1086+1G>T | splice_donor intron | N/A | NP_000847.2 | ||||
| GUCY1A1 | NM_001130683.4 | c.1086+1G>T | splice_donor intron | N/A | NP_001124155.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GUCY1A1 | ENST00000506455.6 | TSL:1 MANE Select | c.1086+1G>T | splice_donor intron | N/A | ENSP00000424361.1 | |||
| GUCY1A1 | ENST00000296518.11 | TSL:1 | c.1086+1G>T | splice_donor intron | N/A | ENSP00000296518.7 | |||
| GUCY1A1 | ENST00000511108.5 | TSL:1 | c.1086+1G>T | splice_donor intron | N/A | ENSP00000421493.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152126Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 245774 AF XY: 0.00
GnomAD4 exome AF: 0.00000231 AC: 3AN: 1298652Hom.: 0 Cov.: 19 AF XY: 0.00000153 AC XY: 1AN XY: 652084 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152126Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74290 show subpopulations
ClinVar
Submissions by phenotype
Moyamoya disease with early-onset achalasia Pathogenic:2
Variant summary: GUCY1A1 c.1086+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing and loss of GUCY1A1 function. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes a 5' splicing donor site. Two predict the variant creates a 5' donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 3.4e-06 in 1450778 control chromosomes. To our knowledge, no occurrence of c.1086+1G>T in individuals affected with Moyamoya Disease With Early-Onset Achalasia and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1323042). Based on the evidence outlined above, the variant was classified as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at